Randomized Strategy

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Fractional dose of scarce meningitis vaccine may be effective in outbreak control

Published December 1, 2008, 5:28 pm, EurekAlert!

( Public Library of Science ) A partial dose of a commonly used vaccine against meningitis may be as effective as a full dose, according to new research published Dec. 2 in the open-access journal PLoS Neglected Tropical Diseases. Fractional dosing would enable large-scale vaccination campaigns during epidemics, especially at a time of global vaccine shortages.

Discover News | Full Story


Spectrum Pharmaceuticals Announces ZEVALIN sBLA Granted Priority Review by the FDA; Target Decision (PDUFA) Date of ...

Published December 1, 2008, 4:19 am, Centre Daily Times

Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI) today announced that its joint venture partner for ZEVALIN, Cell Therapeutics, Inc. (CTI) (NASDAQ:CTIC)(MTA:CTIC), received notice that the U.S. Food and Drug Administration (FDA) has accepted for filing and review, and has granted priority review status for the supplemental Biologics License Application (sBLA) for use of ZEVALINĀ® ([ 90 ...

Discover News | Full Story


Spectrum Pharmaceuticals Announces ZEVALIN sBLA Granted Priority Review by the FDA; Target Decision (PDUFA) Date of ...

Published December 1, 2008, 4:00 am, Business Wire via Yahoo! Finance

IRVINE, Calif.----Spectrum Pharmaceuticals, Inc. today announced that its joint venture partner for ZEVALIN, Cell Therapeutics, Inc. , received notice that the U.S. Food and Drug Administration has accepted for filing and review, and has granted priority review status for the supplemental Biologics License Application for use of ZEVALINĀ® as first line consolidation therapy for patients with ...

Discover News | Full Story


Interim Report for the Period 1 January - 30 September 2008 (Unaudited)

Published November 26, 2008, 2:47 am, PR Newswire via Yahoo! Finance

Exiqon A/S, traded at the NASDAQ OMX Copenhagen , reports continued strong growth in research product sales during the third quarter of 2008. Revenues were positively affected by the execution of a license agreement with Roche Diagnostics for use of Exiqon's LNA technology.

Discover News | Full Story


OrBec(R) Receives Orphan Drug Designation In Australia For The Treatment Of Gastrointestinal Graft-Versus-Host-Disease

Published November 25, 2008, 12:12 pm, Medical News Today

DOR BioPharma, Inc. (DOR or the Company) (OTCBB: DORB), a late-stage biopharmaceutical company, announced today that the Therapeutics Goods Administration (TGA) of Australia has designated orBec(R) as an Orphan Drug for the treatment of patients with gastrointestinal Graft-Versus-Host-Disease (GI GVHD) following allogeneic hematopoietic cell transplantation.

Discover News | Full Story


Chorea Associated With Huntington's Disease Ovation - Nationwide Availability Of Xenazine (tetrabenazine) Tablets In ...

Published November 25, 2008, 11:12 am, Medical News Today

OVATION Pharmaceuticals, Inc. announced today that Xenazine* (tetrabenazine) Tablets, an orphan drug recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of chorea associated with Huntington's disease (HD), is now available throughout the United States. Xenazine is the first and only FDA-approved treatment specifically developed for any HD-related symptom.

Discover News | Full Story


Peer-led Sex Education Does Not Reduce Abortions Among Teenagers

Published November 25, 2008, 8:12 am, Medical News Today

A trial of peer-led sex education in schools in England has found that it is not more effective at reducing teenage abortions than the sex education classes given by teachers.

Discover News | Full Story


Peer-led sex education does not reduce abortions among teenagers

Published November 25, 2008, 4:28 am, PhysOrg

A trial of peer-led sex education in schools in England has found that it is not more effective at reducing teenage abortions than the sex education classes given by teachers. However, the study, published in the open access journal PLoS Medicine, does show that a peer-led approach to sex education is preferred by pupils and suggests it should still be considered as part of a broad strategy to ...

Discover News | Full Story


Peer-led sex education does not reduce abortions among teenagers

Published November 24, 2008, 5:17 pm, EurekAlert!

( Public Library of Science ) A trial of peer-led sex education in schools in England has found that it is not more effective at reducing teenage abortions than the sex education classes given by teachers. However, the study, published in the open access journal PLoS Medicine, does show that a peer-led approach to sex education is preferred by pupils and suggests it should still be considered as ...

Discover News | Full Story


Trendy 'peer led' sex education lessons have no impact

Published November 24, 2008, 4:17 pm, Daily Telegraph

A trendy version of sex education brought in by some schools during the initial AIDS scare has had no impact on the number of teenage abortions or rates of sexually transmitted diseases scientists have found.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a